Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab [...]
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
Guidance for the Use of Disease Modifying Therapies During the COVID-19 pandemic
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]